Índice

• • ·Editorial board

    Página :i

    

• Editorial

  • ·Therapies celebrated its 75th anniversary!

    Therapies a fêté ses 75 ans !

    Página :1-4

    Jean-Louis Montastruc

    Esquema Esquema  

• Pharmacovigilance/Pharmacovigilance

  • ·Calcium channel blocker exposure and psoriasis risk: Pharmacovigilance investigation and literature data

    Página :5-11

    Brahim Azzouz, Delphine Laugier-Castellan, Paola Sanchez-Pena, Marie Rouault, Lukshe Kanagaratnam, Aurore Morel, Thierry Trenque

    Resumen Resumen Esquema Esquema
  • ·Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations

    Página :13-21

    Arun Koyyada

    Resumen Resumen Esquema Esquema

• Thérapeutique/Therapeutics

  • ·Evolution of clotting factor concentrates prescriptions and impact of recommendations of prophylaxis in children with haemophilia

    Página :23-29

    Florianne Bel, Sandrine Meunier, Anne Lienhart, Alban Revy, Valérie Chamouard

    Resumen Resumen Esquema Esquema  

• Addictovigilance/Addictovigilance

  • ·Consommation de substances chez les jeunes : du médicament aux substances illicites

    Substance use among young people: From medicine to illicit substances

    Página :31-35

    Maryse Lapeyre-Mestre, Anne Boyer, Camille Ponté, Amélie Daveluy, Emmanuelle Godeau

    Resumen Resumen Esquema Esquema  

• Pharmacologie clinique/Clinical pharmacology

  • ·Analyse des modifications de statut réglementaire des médicaments en France : 2010–2019

    Analysis of regulatory status changes of drugs in France: 2010–2019

    Página :37-47

    Marie Castanié, Blandine Juillard-Condat, Christian Galian, Jean-Paul Giroud, Haleh Bagheri

    Resumen Resumen Esquema Esquema  

• Lettres à la rédaction/Letters to editor

  • ·Spiderweb-like pattern: A novel dermoscopic feature in photo-onycholysis induced by doxycycline?

    Página :49-50

    Amal Chamli, Fatma Ben Salem, Imene Ben Lagha, Ons Charfi, Anissa Zaouak, Samy Fenniche, Houda Hammami

    Esquema Esquema  
  • ·Myocardial infarction in relation to colchicine poisoning: A precipitating cause of refractory toxic cardiogenic shock

    Página :51-53

    Francis Grossenbacher, Guillaume Giodarno Orsini, Yoann Cazaubon, Pierre Fouret, Zoubir Djerada, Bruno Mégarbane

    Esquema Esquema  
  • ·Augmentation des complications sanitaires graves lors de l’usage non-médical du protoxyde d’azote en France

    Página :53-54

    Association française des centres d’addictovigilance, Joelle Micallef, Michel Mallaret, Maryse Lapeyre-Mestre, Amélie Daveluy, Caroline Victorri-Vigneau, Hélène Peyrière, Danièle Debruyne, Sylvie Deheul, Régis Bordet, Cécile Chevallier, Marie-Christine Perault-Pochat, Reynald Le Boisselier, Frédéric Libert, Leila Chaouachi, Pierre Gillet

    Esquema Esquema
  • ·Enquête satisfaction dans le centre d’investigations cliniques (CIC-1427) de l’hôpital Saint-Louis

    Satisfaction survey in the clinical investigations center (CIC-1427) in Saint-Louis hospital Paris, France

    Página :54-57

    Axelle Dupont, Sylvie Chevret, Claire Montlahuc, Matthieu Resche-Rigon, Yannick Fontaine, Souhil Allaoua, Jean-Jacques Kiladjian, Zineb Ghrieb

    Esquema Esquema   
  • ·The 2019 Global Initiative for Asthma report: Evidence-based or evidence-biased medicine?

    Página :57-58

    Pierre-Olivier Girodet, Matthieu Molimard

    Esquema Esquema
  • ·Olmesartan-associated enteropathy: Belgian survey

    Página :58-60

    Abire Allaoui, Diane Marcoux, Benoit Vokaer, Bruno Couturier

    Esquema Esquema